The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 469-473

  Pertovaara, M ^a,b   Heliovaara M ^c   Raitala, A ^a   Oja, S S ^a,b   Knekt, P ^c   Hurme, M ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

3 dioxygenase; Indoleamine 2; Inflammation; Smoking; T cell

Indexed keywords

AUTOANTIBODY; COTININE; ESSENTIAL AMINO ACID; IMMUNOGLOBULIN; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; TRYPTOPHAN;

ADULT; AGED; AMINO ACID METABOLISM; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FINLAND; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SMOKING; SMOKING HABIT; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; COTININE; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; KYNURENINE; MALE; MIDDLE AGED; SMOKING; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TRYPTOPHAN;

EID: 33747396845     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03166.x     Document Type: Article

References (31)

1. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2:372-7.
2. Ferson M, Edwards A, Lind A, Milton GGW, Hersey P. Low natural-killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23:603-9.
3. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164:2206-16.
4. Tuomi T, Heliövaara M, Palosuo T, Aho K. Smoking, lung function and rheumatoid factors. Ann Rheum Dis 1990; 49:753-6.
5. Heliövaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and the risk of rheumatoid arthritis. J Rheumatol 1993; 20:1830-5.
6. Mattey DL, Dawes PT, Clarke S et al. Relationship among the HLADRB1 shared epitope, smoking and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum 2002; 47:403-7.
7. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50:3085-92.
8. Freemer MM, King TE Jr, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006; 65:581-4. DOI: 10.1136/ard.2005.039438.
9. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20:469-73.
10. Mellor AL, Munn DH. Tryptophan catabolism and regulation of adaptive immunity. J Immunol 2003; 170:5809-13.
11. Mellor AL, Munn DH. Ido expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev Immunol 2004; 4:762-74.
12. Hogg N. Nicotine has suppressive effects on dendritic cell function. Immunology 2003; 109:329-30.
13. Robbins CS, Dawe DE, Goncharova SI et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immunity. Am J Respir Cell Mol Biol 2004; 30:202-11.
14. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999; 107 (Suppl. 2):349-55.
15. Vartiainen E, Seppälä T, Lillsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a community based study. J Epidemiol Commun Health 2002; 56:167-70.
16. Aromaa A. Epidemiology and public health impact of high blood pressure in Finland. Helsinki: Social Insurance Institution, 1981:AL: 17 [in Finnish with English summary].
17. Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute, vol. B12/2004. Helsinki: Hakapaino Oy, 2004.
18. Perkins SL, Livesey JF, Escares EA, Belcher JM, Dudley DK. High-performance liquid-chromatographic method compared with a modified radioimmunoassay of cotinine in plasma. Clin Chem 1991; 37:1989-93.
19. Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002; 48:579-81.
20. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Report 1999; 4:199-220.
21. Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003; 109:365-73.
22. Korpilähde T, Heliövaara M, Knekt P, Marniemi J, Aromaa A, Aho K. Smoking history and serum cotinine and thiocyanate concentrations as determinants of rheumatoid factor in non-rheumatoid subjects. Rheumatology 2004; 43:1424-8.
23. Phaybouth V, Wang SZ, Hutt JA, McDonald JD, Harrod KS, Barrett EG. Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. Am J Physiol Lung Cell Mol Physiol 2006; 290:L222-31.
24. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th2-priming. J Immunol 2005; 175:2684-91.
25. Pertovaara M, Raitala A, Uusitalo H et al. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Clin Exp Immunol 2005; 142:155-61.
26. Pertovaara M, Antonen J, Hurme M. Th2 cytokine genes are associated with a milder form of primary Sjögren's syndrome. Ann Rheum Dis 2006; 65:666-70. DOI: 10.1136/ard.2005.040956.
27. Manthorpe R, Benoni C, Jacobsson L et al. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SS-B/La antibodies in Sjögren's syndrome? Ann Rheum Dis 2000; 59:54-60.
28. Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol Immunol 2006; 43:1054-6. DOI: 10.1016/j.molimm.2005.06.022.
29. Wolf AM, Wolf D, Rumpold H et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 2004; 113:47-55.
30. Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:536-44.
31. Ingram JR, Rhodes J, Evans BK, Thomas GA. Preliminary observations of oral nicotine therapy for inflammatory bowel disease: an open-label phase I-II study of tolerance. Inflamm Bowel Dis 2005; 12:1092-6.